# Utility of Versican and Hyaluronan Measurement in Induced Sputum as Biomarkers of Asthma

> **NCT00980707** · PHASE4 · COMPLETED · sponsor: **Associated Scientists to Help Minimize Allergies** · enrollment: 10 (actual)

## Conditions studied

- Allergic Asthma

## Interventions

- **DRUG:** Inhaled corticosteroid (fluticasone)

## Key facts

- **NCT ID:** NCT00980707
- **Lead sponsor:** Associated Scientists to Help Minimize Allergies
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2010-06
- **Final completion:** 2010-11
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2012-01-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00980707

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00980707, "Utility of Versican and Hyaluronan Measurement in Induced Sputum as Biomarkers of Asthma". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00980707. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*